Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.
about
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an updateAre we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancersSecondary solid cancer screening following hematopoietic cell transplantationLate effects of blood and marrow transplantation.Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesHow I treat late effects in adults after allogeneic stem cell transplantation.Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivorsHuman papillomavirus reactivation following treatment of genital graft-versus-host disease.Tumor necrosis factor blockade and the risk of viral infectionFemale long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution.The biology of papillomavirus latency.Time to consider HPV vaccination after allogeneic stem cell transplantationCan routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation?Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.Immunosuppression facilitates the reactivation of latent papillomavirus infections.Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.Secondary cancers following allogeneic haematopoietic cell transplantation in adults.Clinical practice implications of immunizations after pediatric bone marrow transplant: a literature review.Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD.Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.Clinical management of genital chronic GvHD.[Guidelines for vaccination of immunocompromised individuals].Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia.HPV vaccination of immunocompromised hosts.Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
P2860
Q28079998-2005C14C-021B-4CF9-B8AA-3879B7993BE5Q28088322-10E70A0F-ED39-476F-A504-3EE0A8BE38C4Q28088369-5020A06F-8861-4BC8-9950-499EA53D01F1Q33574136-4278CD5A-69AA-4191-8772-E832E9B7902FQ33822026-F0B7A78E-A270-49D9-8030-DB709D3D23DDQ33965200-965A4605-C94D-47FD-B228-EB5A1D277BD9Q34707208-A9D10E8F-C454-482A-9739-FFDCE310E466Q34711338-56C2CF59-BBF3-4DDF-B5E9-D901C11A4007Q34741675-22D8A5CC-EA2E-4D3A-82D3-C4BBA0EDE24FQ35161630-666963C6-DB0C-4197-8F6C-878578966B72Q35671371-D5FA3467-20BD-4C32-8035-78CF1D9BE3F6Q35875607-15C8D403-7BD8-4D05-B41D-5E57088F27EDQ36540467-E24151A1-EDB5-4A83-B44A-FEE7CB493BDAQ37113925-0AD88332-4847-4FED-A228-7C898C87CC61Q37285453-93CB41FF-F503-4B53-A778-7784A8F7396CQ37347871-9D78366F-9258-4F87-858C-F6C185C45210Q37547649-74D4BCC8-A3DE-4985-BCF7-B17391D47FBDQ37593798-F7196BE7-8743-49AA-9A0F-2084A0BFE60DQ37880254-E1F7DDF5-E0D9-4BD5-8F43-EF6F139647C8Q38060559-3670E36D-EEF2-4985-ABD1-B44DECCEF14BQ38262917-7A316B8D-1967-4290-B456-23816AFCE1EAQ38628809-6E0DED31-F6A0-4653-9AE2-895720A91F97Q38772931-E95F2187-2360-4639-A555-57389C89F8D1Q40600058-54910481-F921-4D40-B03B-3275A6DA374BQ45323659-8A98B2EC-3BC1-4828-AD2D-071C87ED21D7Q46355059-8659BF15-A09E-433B-94AC-40E660E3712FQ47441540-4B554180-DBBA-4BC5-A47C-348700FEFFA9
P2860
Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Increased risk of cervical dys ...... screening and HPV vaccination.
@ast
Increased risk of cervical dys ...... screening and HPV vaccination.
@en
Increased risk of cervical dys ...... screening and HPV vaccination.
@nl
type
label
Increased risk of cervical dys ...... screening and HPV vaccination.
@ast
Increased risk of cervical dys ...... screening and HPV vaccination.
@en
Increased risk of cervical dys ...... screening and HPV vaccination.
@nl
prefLabel
Increased risk of cervical dys ...... screening and HPV vaccination.
@ast
Increased risk of cervical dys ...... screening and HPV vaccination.
@en
Increased risk of cervical dys ...... screening and HPV vaccination.
@nl
P2093
P2860
P1476
Increased risk of cervical dys ...... screening and HPV vaccination.
@en
P2093
A John Barrett
Aarthi Shenoy
Bipin N Savani
Eleftheria Kozanas
Pamela Stratton
Stacey Goodman
P2860
P304
P356
10.1016/J.BBMT.2008.07.005
P577
2008-09-01T00:00:00Z